Kintara Therapeutics, Inc(NASDAQ:KTRA) 
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant...
Website: https://www.kintara.com/
Founded: 2009
CEO: Saiid Zarrabian
Sector: Manufacturing
Industry: Polish and Other Sanitation Good Manufacturing
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-09
P
O 0.29
H 0.30
L 0.27
C 0.28
V 3,400,929
10EMA 0.28
20EMA 0.28
60EMA 0.28
120EMA 0.28
250EMA 0.28